MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Moderate-to-severe upper limb spasticity patterns in the elderly are improved following treatment with incobotulinumtoxinA: a pooled analysis

    M. Munin, A. Camões-Barbosa, C. Cordero-García, M. Althaus, G. Comes, M. Vacchelli, C. Walter, J. Wissel (Pittsburgh, USA)

  • Moderators of aerobic exercise effects on motor symptoms in patients with Parkinson’s disease: a systematic review and meta-analysis

    R. Kim, N. Kang (Seoul, Republic of Korea)

  • Modifiable factors associated with Huntington’s disease progression in presymptomatic participants: explained longitudinal machine learning modelling

    A. Gil-Salcedo, R. Massart, L. Cleret-de-Langavant, A. Bachoud-Levi (Paris, France)

  • Molecular Landscape of Gastrointestinal Dysfunctions in Parkinson’s Disease

    M. Lai, S. Kulkarni, B. Benitez (Boston, USA)

  • Monitoring Progress: Use of the Behavioral Dyscontrol Scale-2 (BDS-2) in FXTAS (Fragile X-associated Tremor Ataxia Syndrome) Progression

    H. Hasan, A. Mokhtabad Amrei, E. Santos, H. Biag, A. Schneider, J. Wang, R. Hagerman (Sacramento, USA)

  • Monopolar sensing improves the efficiency of DBS programming in Parkinson’s disease

    J. Thompson, E. Radcliffe, S. Ojemann, D. Kramer, A. Baumgartner, D. Kern, M. Case, C. Zarns, A. Holt-Becker, R. Raike (Aurora, USA)

  • Mood and Apathy Outcomes after STN or GPi DBS for Parkinson’s Disease: An Interim Report from the ADROIT NAPA Sub-study

    S. Groppa, M. Figee, I. Muro Garcia, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, A. Gharabaghi (Mainz, Germany)

  • Morphology and Functional Connectivity of the Basolateral Amygdala and Rapid Eye Movement Sleep Behavior Disorder

    Z. Song, Z. Wang, B. Zhang, J. Pu (Hangzhou, China)

  • Mortality Rate, Cause of Death and Factors Associated with Mortality in Late Stage Parkinson’s Disease

    K. Rosqvist, P. Odin (Lund, Sweden)

  • Motion-robust high-resolution imaging of nigrosome-1 in Parkinson’s disease

    M. Skorpil, O. Norbeck, P. Svenningsson, S. Skare, A. van Niekerk (Stockholm, Sweden)

  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley